EUPRAXIA PHARMACEUTICALS INC (EPRX): Institutional Ownership
Hedge funds and institutional managers reporting a position in EPRX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$12.3M
Across holders
Last Price
$6.60
2026-06-26
Sector
Health Care
GICS
Holder activity3 new0 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 1.35M | $9.8M | 79.8% | 0.0% | Unchanged | +$0 | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 216K | $1.6M | 12.8% | 0.0% | New | — | Q1 2026 |
| Hudson Bay Capital Management LP CIK 0001393825 | Hedge Fund | 92K | $669K | 5.5% | 0.0% | New | — | Q1 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 23K | $166K | 1.4% | 0.0% | Reduced | $-812K | Q1 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 11K | $78K | 0.6% | 0.0% | New | — | Q1 2026 |
Unchanged
Hedge Fund
$9.8M· 79.8% of total· 0.0% port· 1.35M sh· +$0 QoQ· Q1 2026
New
Hedge Fund
$1.6M· 12.8% of total· 0.0% port· 216K sh· — QoQ· Q1 2026
New
Hedge Fund
$669K· 5.5% of total· 0.0% port· 92K sh· — QoQ· Q1 2026
Reduced
Hedge Fund
$166K· 1.4% of total· 0.0% port· 23K sh· $-812K QoQ· Q1 2026
New
Hedge Fund
$78K· 0.6% of total· 0.0% port· 11K sh· — QoQ· Q1 2026